TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy

BrightSpring Health Services, Inc. (NASDAQ:BTSG) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds. On June 23, TD Cowen initiated coverage of BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s stock with a “Buy” rating and a price objective of $37. The firm mentioned the company’s position as a leading oncology-focused specialty pharmacy and home health provider, highlighting that it stands to benefit due to the continued specialty growth in the broader healthcare sector.

TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy

A pharmacist wearing a lab coat standing in front of a pharmacy automation solution.

Furthermore, the firm also cited the advantages for BrightSpring Health Services, Inc. (NASDAQ:BTSG) coming from the generic wave due to pharma’s upcoming patent cliff as a critical factor responsible for the positive outlook. Also, the firm stated that its price objective demonstrates that BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s stock trades at 15 times its adjusted EBITDA estimate for FY 2026.

For FY 2025, the company has increased its guidance, which excludes the Community Living business and the effects related to future closed acquisitions. BrightSpring Health Services, Inc. (NASDAQ:BTSG) expects net revenue of between $12,000 million – $12,500 million, or 19.1% – 24.1% growth, with Pharmacy Segment revenue of between $10,550 million – $11,000 million, or 20.5% – 25.7% growth.

While we acknowledge the potential of BTSG to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BTSG and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None.